Abbvie Announces Q4 Dividend of $1.64/Share, Payable Nov 14, 2025
ByAinvest
Friday, Sep 5, 2025 11:08 am ET1min read
ABBV--
Since its inception in 2013, AbbVie has increased its dividend by 310 percent, demonstrating its dedication to consistent dividend growth. The company is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years [1][2].
Institutional investors have shown interest in AbbVie's stock, with AQR Capital Management LLC reducing its stake by 46.6% and TD Capital Management LLC increasing its stake by 82.9% during the first quarter of 2025 [3]. Despite the high dividend payout ratio of 312.38%, the company continues to maintain strong financial stability and a focus on shareholder value.
AbbVie's recent earnings report showed earnings per share (EPS) of $2.97 for the quarter, missing analysts' consensus estimates by ($0.27) [3]. The company reported revenue of $15.42 billion during the quarter, up 6.6% year-over-year. AbbVie's strong pipeline and product portfolio continue to drive its financial performance.
Several equities research analysts have rated AbbVie's stock positively, with a consensus rating of "Moderate Buy" and a target price of $214.95 [3]. The company's market capitalization stands at $373.79 billion, with a PE ratio of 100.76 and a beta of 0.53 [3].
References:
[1] https://finance.yahoo.com/news/abbvie-declares-quarterly-dividend-130700697.html
[2] https://www.stocktitan.net/news/ABBV/abb-vie-declares-quarterly-qytl2w19gesy.html
[3] https://www.marketbeat.com/instant-alerts/filing-abbvie-inc-abbv-shares-sold-by-aqr-capital-management-llc-2025-09-04/
[4] https://www.streetinsider.com/Dividends/AbbVie+%28ABBV%29+Declares+%241.64+Quarterly+Dividend%3B+3.1%25+Yield/25301477.html
Abbvie Inc. declared a quarterly cash dividend of $1.64 per share. The dividend is payable on November 14, 2025, to stockholders of record on October 15, 2025.
AbbVie Inc. (NYSE: ABBV) has announced a quarterly cash dividend of $1.64 per share, payable on November 14, 2025, to stockholders of record on October 15, 2025 [1][2][4]. This dividend represents an annualized rate of $6.56 and a yield of 3.1%, reflecting the company's commitment to shareholder returns.Since its inception in 2013, AbbVie has increased its dividend by 310 percent, demonstrating its dedication to consistent dividend growth. The company is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years [1][2].
Institutional investors have shown interest in AbbVie's stock, with AQR Capital Management LLC reducing its stake by 46.6% and TD Capital Management LLC increasing its stake by 82.9% during the first quarter of 2025 [3]. Despite the high dividend payout ratio of 312.38%, the company continues to maintain strong financial stability and a focus on shareholder value.
AbbVie's recent earnings report showed earnings per share (EPS) of $2.97 for the quarter, missing analysts' consensus estimates by ($0.27) [3]. The company reported revenue of $15.42 billion during the quarter, up 6.6% year-over-year. AbbVie's strong pipeline and product portfolio continue to drive its financial performance.
Several equities research analysts have rated AbbVie's stock positively, with a consensus rating of "Moderate Buy" and a target price of $214.95 [3]. The company's market capitalization stands at $373.79 billion, with a PE ratio of 100.76 and a beta of 0.53 [3].
References:
[1] https://finance.yahoo.com/news/abbvie-declares-quarterly-dividend-130700697.html
[2] https://www.stocktitan.net/news/ABBV/abb-vie-declares-quarterly-qytl2w19gesy.html
[3] https://www.marketbeat.com/instant-alerts/filing-abbvie-inc-abbv-shares-sold-by-aqr-capital-management-llc-2025-09-04/
[4] https://www.streetinsider.com/Dividends/AbbVie+%28ABBV%29+Declares+%241.64+Quarterly+Dividend%3B+3.1%25+Yield/25301477.html

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet